According to a new analysis from the U.S. Department of Health and Human Services (HHS), extending Medicare immunosuppressive drug coverage for kidney transplant recipients for more than three years post-transplant would result in Medicare savings of $73.4 million over 10 years. READ MORE >>TOPICS: Policy, Medicare
Learn about best practices in engaging your elected officials, and the public policy issues affecting health care and kidney disease.
On April 29, KidneyX announced 15 winning teams for its Phase 1 Redesign Dialysis prize competition. Winning teams’ solutions focused on areas such as improving patient quality of life, earlier detection of complications, and improving patient outcomes. Each team won a prize of $75,000. READ MORE >>TOPICS: Research
On April 3, the American Kidney Fund (AKF) hosted its annual Advocacy Day on Capitol Hill. Twenty-seven AKF Ambassadors from 19 states and the District of Columbia gathered in our nation’s capital to share their personal stories with kidney disease, and to advocate on key issues affecting kidney patients. READ MORE >>TOPICS: Charitable Premium Assistance, Legislation, AKF Advocacy Activities, Advocacy day, Policy, Advocates
To kick off National Minority Health Month, join the American Kidney Fund (AKF) for a briefing on the disproportionate impact of kidney disease on people of color and new research initiatives addressing kidney disease. READ MORE >>TOPICS: Legislation, Advocacy day, Policy, Congressional Update, Advocates
Legislation that would protect living organ donors from discrimination and encourage organ donation has been reintroduced this year in the U.S. Congress. READ MORE >>TOPICS:
On Thursday, March 14—World Kidney Day—I was honored and excited to join a group of Illinois advocates—including 8 other AKF Ambassadors—to support kidney health and living donor legislation at the State Capitol in Springfield, Illinois. READ MORE >>TOPICS: Legislation, Policy, Advocates, Action Alerts